Clinical trials
Phase 3 Scleroderma, Diffuse trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2003 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 5 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| MediQuest Therapeutics | 4 |
| Federal University of São Paulo | 3 |
| Johns Hopkins University | 3 |
| Sanjay Gandhi Postgraduate Institute of Medical Sciences | 3 |
| Khon Kaen University | 2 |
| Actelion | 1 |
| Allergan | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| AstraZeneca | 1 |
| Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scleroderma, Diffuse | 28 |
| Scleroderma, Systemic | 13 |
| Raynaud Disease | 9 |
| Lung Diseases, Interstitial | 6 |
| Autoimmune Diseases | 3 |
| Connective Tissue Diseases | 3 |
| Arthritis, Rheumatoid | 2 |
| Pulmonary Fibrosis | 2 |
| Anorexia | 1 |
| Dry Eye Syndromes | 1 |
Trials
Showing 26 to 28 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.